• ABOUT
    • About MakingLife
    • About MakingPharmaindustry
    • Contact us
  • PUBBLICATIONS
    • MakingPharmaIndustry
  • RESEARCH
    • Clinical research
    • Technology
  • MANUFACTURING
    • BioDrugs & ATMP
    • Contract manufacturing
    • GMP
    • Production lines & equipments
    • API & Excipients
    • Packaging
    • Quality & Validation
    • PHARMA ENGINEERING by ISPE
    • Technology
    • SUPPLEMENTS
  • REGULATORY
    • Guidelines
    • Legislation
    • Pharmacovigilance
  • SUPPLY CHAIN
    • Blockchain
    • GDP
    • Artificial intelligence
    • Logistics
    • Management
    • Security and privacy
  • DIGITAL HEALTH
    • Medical devices
    • Telemedicine
    • Digital Therapies
  • BUSINESS
    • EVENTS
    • Corporate Social Responsibility
    • Deal & Finance
    • Digital transformation
    • Diversity & Inclusion
    • ESG
    • Insights
    • Leadership changes
    • Leadership lessons
    • Marketing & Communication
    • Market
    • Human resources
    • Startup
  • EIPG NEWS
Search
Logo
Logo
    • English
    • Italian
  • ABOUT
    • About MakingLife
    • About MakingPharmaindustry
    • Contact us
  • PUBBLICATIONS
    • MakingPharmaIndustry
  • RESEARCH
    • Clinical research
    • Technology
  • MANUFACTURING
    • BioDrugs & ATMP
    • Contract manufacturing
    • GMP
    • Production lines & equipments
    • API & Excipients
    • Packaging
    • Quality & Validation
    • PHARMA ENGINEERING by ISPE
    • Technology
    • SUPPLEMENTS
  • REGULATORY
    • Guidelines
    • Legislation
    • Pharmacovigilance
  • SUPPLY CHAIN
    • Blockchain
    • GDP
    • Artificial intelligence
    • Logistics
    • Management
    • Security and privacy
  • DIGITAL HEALTH
    • Medical devices
    • Telemedicine
    • Digital Therapies
  • BUSINESS
    • EVENTS
    • Corporate Social Responsibility
    • Deal & Finance
    • Digital transformation
    • Diversity & Inclusion
    • ESG
    • Insights
    • Leadership changes
    • Leadership lessons
    • Marketing & Communication
    • Market
    • Human resources
    • Startup
  • EIPG NEWS
Home Authors Posts by Simone Montonati

Simone Montonati

153 POSTS 0 COMMENTS
Life science raw ingredients: will 2024 be the year of recovery?
API & Excipients

Life science raw ingredients: will 2024 be the year of recovery?

Simone Montonati -
December 26, 2023
0
European packaging regulation: ‘single market at risk’ according to associations
ESG

European packaging regulation: ‘single market at risk’ according to associations

Simone Montonati -
December 26, 2023
0
The rules of attraction (for assets)
Market

The rules of attraction (for assets)

Simone Montonati -
November 9, 2023
0
Roche takes aim at inflammatory bowel disease
Deal & Finance

Roche takes aim at inflammatory bowel disease

Simone Montonati -
November 5, 2023
0
Sanofi’s strategic turnaround
Deal & Finance

Sanofi’s strategic turnaround

Simone Montonati -
October 29, 2023
0
Goodbye NASH, it’s Alfasigma’s time
Deal & Finance

Goodbye NASH, it’s Alfasigma’s time

Simone Montonati -
October 17, 2023
0
APIs between market opportunities and geopolitical risks
Market

APIs between market opportunities and geopolitical risks

Simone Montonati -
October 4, 2023
0
Biosimilars, a 1.6 billion euro saving
Market

Biosimilars, a 1.6 billion euro saving

Simone Montonati -
September 21, 2023
0
The pharma green revolution (still missing)
Corporate Social Responsibility

The pharma green revolution (still missing)

Simone Montonati -
September 15, 2023
0
1...456Page 5 of 6
  • English
  • Italian